Navigation Links
Some Kids Respond Better to ADHD Drug Than Others
Date:10/23/2011

FRIDAY, Oct. 21 (HealthDay News) -- Children with specific gene variants respond better to the drug methylphenidate (Ritalin, Concerta), which is widely used to treat attention-deficit hyperactivity disorder (ADHD), a new study says.

The finding could help improve treatment of ADHD, according to the Cincinnati Children's Hospital Medical Center researchers.

"Physicians don't have a good way of predicting who will experience great improvement in ADHD symptoms with a particular medication, so currently we use a trial-and-error approach. Unfortunately, as a result, finding an effective treatment can take a long time," lead investigator Dr. Tanya Froehlich, a physician in the division of developmental and behavioral pediatrics, said in a medical center news release.

"With more information about genes that may be involved in ADHD medication response, we may be able to predict treatment course, tailor our approach to each child, and improve symptom response while decreasing health care costs," she said.

The researchers tested 89 children aged 7 to 11 with ADHD and found that those with specific variants of the dopamine transporter (DAT) and dopamine receptor D4 (DRD4) genes showed greater improvement in hyperactivity and impulsivity after taking methylphenidate than those without the gene variants.

Specifically, children with the DAT 10-repeat variant and the DRD4 gene 4-repeat showed more response to methylphenidate than those without the variants. A repeat is a short nucleotide coding sequence in a gene that's repeated.

The study was published Oct. 21 in the Journal of the American Academy of Child and Adolescent Psychiatry.

Further research in a larger number of patients is needed to confirm these findings and their clinical significance, the researchers said.

More information

The U.S. National Institute of Mental Health has more about attention deficit hyperactivity disorder.

-- Robert Preidt

SOURCE: Cincinnati Children's Hospital Medical Center, news release, Oct. 17, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. For Valentine's Day, Lifestyle Correspondent and Her Two Sets of Twins Show a Little Love Where Its Needed the Most
2. FriendsofWater.com Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
3. American Red Cross Responds Internationally and at Home to Chile Quake
4. AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
5. AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
6. Airway Injury Plaguing 9/11 First Responders
7. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
8. Tumors may respond to extreme and moderate heat
9. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
10. Many WTC Responders Show Signs of Heart Trouble
11. Astellas Responds to OSI Pharmaceuticals Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... The Dream Builders Project, a 501(c)3 nonprofit organization ... Eunime Orphanage in Tijuana, Mexico on Saturday, May 21st. The volunteers took the children ... , More than 15 volunteers traveled from Los Angeles to Tijuana, Mexico for ...
(Date:5/24/2016)... PA (PRWEB) , ... May 24, 2016 , ... ... manufacturer of safety signs and safety labels , has been ... “Understanding Symbols: Laser Labels.” , The eiXtra e-newsletter provides electroindustry professionals with manufacturer, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Global Lyme Alliance (GLA), ... announced that it has named Scott Santarella as its new CEO. , ... Foundation (ALCF) in San Francisco, where he successfully helped to grow the organization ...
(Date:5/24/2016)... ... 24, 2016 , ... After graduating from Cornell, author Joshua Alexander ... on medication, living on Social Security disability and staying in a group home. In ... It!” (published by Balboa Press), Alexander shares how he was finally able to heal ...
(Date:5/24/2016)... ... , ... PhysicianOne Urgent Care, advocators in helping their patients lead the healthiest ... being bitten this spring. , The official tick season kicks off in May ... known for attaching themselves to their prey while they feed off their blood. Like ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LAWRENCEVILLE, N.J. , May 24, 2016 /PRNewswire/ ... an oncology drug development company, today provided an ... Ib dose escalating clinical trial combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  GEN-1 is an IL-12 ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 ... , the world , s ... and AV fistula intervention   OrbusNeich, a ... solutions, has expanded its portfolio to include products to ... balloons are the company,s first entry devices for lower ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology: